Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Remdesivir
nsp12
Approved by FDA Experimental Antiviral Jan/18/2023
rlcv-miR-rL1-28-3p
nsp12
Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021
aly-miR396a-5p
nsp12
Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021
Mefuparib hydrochloride
nsp12
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/26/2021